- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05011630
Specific Bile Microorganisms Caused Intra-abdominal Abscess on Pancreaticoduodenectomy Patients: Customized Antibiotics And Antifungal Medication May Be Necessary
Background Intra-abdominal abscess (IAA) is one of the most serious surgical infectious complications on pancreaticoduodenectomy (PD) patients. Preoperative biliary drainage (PBD) is considered as a risk of surgical infectious complications. However, the reason why PBD caused IAA was unknown. In this study, we hypothesize that bile contamination may increase the rate of IAA as bile from residual common bile duct (CBD) leaks and contaminates the abdominal cavity.
Methods We retrospectively collected PD patients with performance of bile culture between 2007 and 2019 in our institute. As to bile culture, we used a swab to do intraoperative bile cultures after transection of the CBD. IAA was defined as a postoperative fluid collection managed by CT-guided placement of drains with documental bacteriological culture.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- all pancreaticoduodenectomy patients
Exclusion Criteria:
- no bile cultures
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
IAA group
Intraabdominal abscess (IAA) is defined as either a turbid discharge from the intraoperatively placed drain or a postoperative fluid collection managed by CT-guided placement of drains with documental bacteriological culture.
|
The incidece of IAA after pancreaticoduodectomy; to validate the risk factors of IAA
|
|
Non-IAA group
No IAA formation
|
The incidece of IAA after pancreaticoduodectomy; to validate the risk factors of IAA
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intraabdominal abscess
Time Frame: 1 month after surgery
|
The abscess formation after surgery
|
1 month after surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jin-Ming Wu, MD, National Taiwan University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201803035RIND
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intraabdominal Abscess After Procedure
-
Chang Wei-JungCompletedPneumonia | Intraabdominal Abscess After Procedure | Leakage | Operation Wound; Infection
-
Odense University HospitalCompletedWound Infection | Intraabdominal AbscessDenmark
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedAbdominal AbscessTaiwan
-
Ronald Kaufman, MDCompletedUrethral Catheter Removal After Urologic ProcedureUnited States
-
BayerCompletedAbscess, Intra-Abdominal | Secondary PeritonitisChina
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Spaarne GasthuisZonMw: The Netherlands Organisation for Health Research and DevelopmentNot yet recruitingIntra-Abdominal Abscess | Complicated Appendicitis
-
The University of Texas Health Science Center,...National Center for Advancing Translational Sciences (NCATS)Recruiting
-
Children's Mercy Hospital Kansas CityCompleted
-
Helsinki University Central HospitalCompleted
Clinical Trials on Pancreaticoduodenectomy
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruitingPancreatic Cancer Resectable
-
Tongji HospitalShanxi Province Cancer Hospital; Fudan University; Qilu Hospital of Shandong... and other collaboratorsEnrolling by invitationPeriampullary AdenocarcinomaChina
-
Tongji HospitalGuangdong Provincial Hospital of Traditional Chinese Medicine; Peking Union... and other collaboratorsUnknownSurgery | Periampullary Cancer | Pancreatic Ductal AdenocarcinomaChina
-
The First Affiliated Hospital of University of...Not yet recruitingPancreatic Cancer | Common Bile Duct Diseases | Periampullary Carcinoma
-
Minia UniversityRecruitingPancreatic Ductal Adenocarcinoma | Pancreatic Neuroendocrine Tumor | Distal Cholangiocarcinoma | Ampullary Carcinoma | Duodenal AdenocarcinomaEgypt
-
Ruijin HospitalIntuitive SurgicalCompletedPancreatic Adenocarcinoma | Chronic Pancreatitis | Ampullary Adenocarcinoma | Cholangiocarcinoma, Extrahepatic | Pancreatic Cysts | Pancreatic Endocrine Tumors | Duodenal AdenocarcinomaChina
-
Duke UniversityCompletedPancreatic Disease
-
Peking Union Medical College HospitalRecruitingThe Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer (MIOPP)Surgery | Pancreatic CarcinomaChina
-
University Hospital Plymouth NHS TrustUniversity of PlymouthCompletedPancreatic Cancer | Surgery | Bile Duct Cancer | Pancreatic Ductal Adenocarcinoma | Survivorship | Cholangiocarcinoma, Extrahepatic | Cancer Recurrence | Recurrent Cancer | Pancreatic Ductal Carcinoma | Cholangiocarcinoma of the Extrahepatic Bile Duct | Ampullary Cancer | Cholangiocarcinoma Resectable | Cancer... and other conditionsSpain, United Kingdom, Australia, Austria, Italy, Mexico, Sudan, Pakistan